No description available.

No description available.

Microvascular dysfunction is believed to precede the development and contribute to the progression of obesity related diseases such as insulin resistance, hypertension, and coronary artery disease. Multiple studies have found impaired microvascular endothelium-dependent vasodilation occurs prior to the onset of disease in middle aged adults. In order to test the hypothesis that the cutaneous microvasculature of young obese (BMI>30kg/m²), but otherwise healthy, adults would exhibit impaired microvascular response, we recruited 12 obese and 12 lean (BMI<25 kg/m²) individuals. Each group was age-matched and consisted of 5 females and 7 males. Each participant was instrumented with two microdialysis probes inserted in the dermis of the non-dominant forearm for a wide dose range of infusions of either the endothelium-dependent vasodilator methacholine (MCh) or the endothelium-independent vasodilator sodium nitroprusside (SNP). Each microdialysis site was clamped at 33°C with a local heater and affixed with a laser Doppler flux (LDF) probe for determination of local red blood cell flux, an index of blood flow. LDF was recorded continuously while 7 doses of each drug (MCh: 10⁻³-10³mM; SNP: 5x10⁻⁵-50mM) were infused at a rate of 2 [mu]l/min for 8 minutes per dose. Both sites finished with heating to 43°C and infusion of 50mM SNP to confirm site specific maximal vasodilation. Blood pressure was recorded in the last minute of each stage and the corresponding LDF was used to calculate cutaneous vascular conductance (CVC). Dose response curves for CVC at each dose, as well as maximal CVC were analyzed. MCh dose response showed a trend toward endothelium–dependent impairment in obese (p=0.06) and maximal absolute CVC at the MCh site was attenuated in obese versus lean (2.70 ± 0.73 vs 3.30 ± 0.81 LDF/mmHg, p=0.027). Endothelium-independent vasodilation with SNP was impaired at the 4 highest doses of SNP (all P<0.006) and maximal CVC was attenuated in obese compared to lean (2.44 ± 0.74 vs 3.31 ± 0.65 LDF/mmHg, p=0.004). These results support the hypothesis that microvascular function is impaired in young, healthy obese, individuals; however they suggest the impairment is partially endothelium-independent. / text

<p>During a cardiac cycle the cardiac walls change between contracted and relaxed and the valves open and close in response to pressure changes. This master thesis is a study of the changes in heart movement pattern caused by intravenous injections of Ca2+ or Nitroprusside. At Stanford University radiopaque markers have been surgically implanted in the walls and in the mitral valve of ovine hearts and 3D coordinates for each marker have been constantly measured during the cardiac cycle. By using MatLab, the volume and pressure of the left ventricle and several parameters related to the opening kinematics of the mitral valve have been analyzed. The results show, among others, that both Ca2+ and Nitroprusside reduce the volume and pressure of the left ventricle and that both substances decrease the size of the mitral annular ring. It was also shown that Ca2+ delays the opening of the mitral valve.</p>

During a cardiac cycle the cardiac walls change between contracted and relaxed and the valves open and close in response to pressure changes. This master thesis is a study of the changes in heart movement pattern caused by intravenous injections of Ca2+ or Nitroprusside. At Stanford University radiopaque markers have been surgically implanted in the walls and in the mitral valve of ovine hearts and 3D coordinates for each marker have been constantly measured during the cardiac cycle. By using MatLab, the volume and pressure of the left ventricle and several parameters related to the opening kinematics of the mitral valve have been analyzed. The results show, among others, that both Ca2+ and Nitroprusside reduce the volume and pressure of the left ventricle and that both substances decrease the size of the mitral annular ring. It was also shown that Ca2+ delays the opening of the mitral valve.

Orientador: Devaney Ribeiro do Carmo / Banca: Newton Luiz Dias Filho / Banca: Jeosadaque José de Sene / Resumo: O objetivo deste trabalho esta resumido através de três etapas. 1 - A primeira etapa consistiu em funcionalizar e caracterizar a sílica gel com grupos 3- aminopropiltrietoxisilano. Nesta etapa o material obtido (Si) foi caracterizado por técnicas de Ressonância Magnética Nuclear no estado sólido (24Si e 13C) e espectroscopia vibracional (FTIR). 2- Numa segunda etapa promoveu-se a adsorção de íons de cobre (II) e de cobalto (II) na superfície da sílica (Si). Os materiais obtidos (SiCu e SiCo) foram caracterizados por espectroscopia vibracional e voltametria cíclica. 3- Na terceira etapa reagiu-se os materiais preparados (SiCu e SiCo) com nitroprussiato de sódio para formar os complexos binucleares (SiCuNP e SiCoNP). Estes materiais também foram caracterizados por espectroscopia vibracional e voltametria cíclica. Estes materiais foram utilizados na construção do eletrodo de pasta de grafite e testados na oxidação eletrocatalítica de substâncias biologicamente importantes tais como a hidrazina e N-acetilcisteína sendo empregado para isto a técnica de voltametria cíclica. Observou-se que o eletrodo de SiCuNP apresentam dois pares redox nos potenciais (Em)1 = 0,34 V e (Em)2 = 0,76 V vs Ag/AgCl, O primeiro foi atribuído ao processo de oxidação do par Cu(I)/Cu(II) e o segundo ao processo de oxidação Fe(II)(CN)5NO / Fe(III)(CN)5NO do complexo binuclear. O sistema SiCoNP foram observados dois pares redox distintos com os seguintes potenciais médios (Em); (Em)1 = 0,29 V e (Em)2 = 0,56 V vs Ag/AgCl, o primeiro foi atribuído ao processo redox do par Co(II)/Co(III) e o segundo ao processo redox Fe(II)(CN)5NO / Fe(III)(CN)5NO do complexo binuclear formado. O sistema SiCuNP foi sensível a concentração de hidrazina apresentando um limite de detecção e sensibilidade amperométrica de 3,07×10-4 mol L-1 e 5,84×10-6 A / mol L-1... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: The objective of this work is summarized in three stages. 1 - The first stage functionalizes and characterizes the silica gel with 3-aminopropyltriethoxysilane groups. At this stage the material obtained (Si) was characterized by solid state Nuclear Magnetic Resonance techniques (24Si and 13C) and vibrational spectroscopy (FTIR). 2 - The second stage promotes the adsorption of copper (II) and cobalt (II) ions on the surface of the silica (Si). The materials obtained (SiCu and SiCo) were characterized by vibrational spectroscopy and cyclic voltammetry. 3 - The third stage prepares the reaction of the materials (SiCu and SiCo) with sodium nitroprusside to form the binuclear complex (SiCuNP and SiCoNP). These materials were characterized by vibrational spectroscopy and cyclic voltammetry. These materials were used to construct the electrode carbon paste and were tested for electrocatalytic oxidation of biologically important substances such as hydrazine and N-acetylcysteine using the cyclic voltammetry technique. It was observed that the electrode SiCuNP has two redox pairs in the potential (Em)1 = 0.34 V and (Em)2 = 0.76 V vs. Ag/AgCl, the first was attributed to the oxidation process of the pair Cu(I)/Cu(II) and the second to the oxidation process Fe(II)(CN)5NO / Fe(III)(CN)5NO of the binuclear complex. For the SiCoNP system, two distinct redox couples were observed with the following mean potentials (Em); (Em)1 = 0.29 V and (Em)2 = 0.56 V vs Ag/AgCl, the first one was assigned to the redox process of the Co(II)/Co(III) pair and the second one to the redox process Fe(II)(CN)5NO / Fe(III)(CN)5NO of the binuclear complex formed. The SiCuNP system was sensitive to the hydrazine concentration, exhibiting a detection limit and amperometric sensitivity of 3.07×10-4 mol L-1 and 5.84×10-6 A / mol L-1 respectively and was also... (Summary complete electronic access click below) / Mestre

Made available in DSpace on 2014-06-11T19:25:32Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-01-26Bitstream added on 2014-06-13T19:12:22Z : No. of bitstreams: 1 sa_ac_me_ilha.pdf: 1061286 bytes, checksum: b370fdf160f4689709efe584af803c2a (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / O objetivo deste trabalho esta resumido através de três etapas. 1 - A primeira etapa consistiu em funcionalizar e caracterizar a sílica gel com grupos 3- aminopropiltrietoxisilano. Nesta etapa o material obtido (Si) foi caracterizado por técnicas de Ressonância Magnética Nuclear no estado sólido (24Si e 13C) e espectroscopia vibracional (FTIR). 2- Numa segunda etapa promoveu-se a adsorção de íons de cobre (II) e de cobalto (II) na superfície da sílica (Si). Os materiais obtidos (SiCu e SiCo) foram caracterizados por espectroscopia vibracional e voltametria cíclica. 3- Na terceira etapa reagiu-se os materiais preparados (SiCu e SiCo) com nitroprussiato de sódio para formar os complexos binucleares (SiCuNP e SiCoNP). Estes materiais também foram caracterizados por espectroscopia vibracional e voltametria cíclica. Estes materiais foram utilizados na construção do eletrodo de pasta de grafite e testados na oxidação eletrocatalítica de substâncias biologicamente importantes tais como a hidrazina e N-acetilcisteína sendo empregado para isto a técnica de voltametria cíclica. Observou-se que o eletrodo de SiCuNP apresentam dois pares redox nos potenciais (Em)1 = 0,34 V e (Em)2 = 0,76 V vs Ag/AgCl, O primeiro foi atribuído ao processo de oxidação do par Cu(I)/Cu(II) e o segundo ao processo de oxidação Fe(II)(CN)5NO / Fe(III)(CN)5NO do complexo binuclear. O sistema SiCoNP foram observados dois pares redox distintos com os seguintes potenciais médios (Em); (Em)1 = 0,29 V e (Em)2 = 0,56 V vs Ag/AgCl, o primeiro foi atribuído ao processo redox do par Co(II)/Co(III) e o segundo ao processo redox Fe(II)(CN)5NO / Fe(III)(CN)5NO do complexo binuclear formado. O sistema SiCuNP foi sensível a concentração de hidrazina apresentando um limite de detecção e sensibilidade amperométrica de 3,07×10-4 mol L-1 e 5,84×10-6 A / mol L-1... / The objective of this work is summarized in three stages. 1 - The first stage functionalizes and characterizes the silica gel with 3-aminopropyltriethoxysilane groups. At this stage the material obtained (Si) was characterized by solid state Nuclear Magnetic Resonance techniques (24Si and 13C) and vibrational spectroscopy (FTIR). 2 - The second stage promotes the adsorption of copper (II) and cobalt (II) ions on the surface of the silica (Si). The materials obtained (SiCu and SiCo) were characterized by vibrational spectroscopy and cyclic voltammetry. 3 - The third stage prepares the reaction of the materials (SiCu and SiCo) with sodium nitroprusside to form the binuclear complex (SiCuNP and SiCoNP). These materials were characterized by vibrational spectroscopy and cyclic voltammetry. These materials were used to construct the electrode carbon paste and were tested for electrocatalytic oxidation of biologically important substances such as hydrazine and N-acetylcysteine using the cyclic voltammetry technique. It was observed that the electrode SiCuNP has two redox pairs in the potential (Em)1 = 0.34 V and (Em)2 = 0.76 V vs. Ag/AgCl, the first was attributed to the oxidation process of the pair Cu(I)/Cu(II) and the second to the oxidation process Fe(II)(CN)5NO / Fe(III)(CN)5NO of the binuclear complex. For the SiCoNP system, two distinct redox couples were observed with the following mean potentials (Em); (Em)1 = 0.29 V and (Em)2 = 0.56 V vs Ag/AgCl, the first one was assigned to the redox process of the Co(II)/Co(III) pair and the second one to the redox process Fe(II)(CN)5NO / Fe(III)(CN)5NO of the binuclear complex formed. The SiCuNP system was sensitive to the hydrazine concentration, exhibiting a detection limit and amperometric sensitivity of 3.07×10-4 mol L-1 and 5.84×10-6 A / mol L-1 respectively and was also... (Summary complete electronic access click below)

INTRODUÇÃO: A esquizofrenia é um transtorno que se caracteriza pela desorganização de diversos processos mentais, dentre os quais a cognição. Pacientes com esquizofrenia apresentam alterações na amplitude e latência dos potenciais evocados P300 e MMN. A maioria das drogas antipsicóticas atuais têm pouco efeito sobre os sintomas negativos e prejuízos cognitivos dos pacientes, por isso, pesquisadores têm buscado alternativas farmacológicas que possam agir sobre os prejuízos cognitivos e sintomas negativos. Pesquisas recentes demonstraram que o nitroprussiato de sódio (NPS) é capaz de atenuar algumas das manifestações do transtorno que não respondem adequadamente aos tratamentos hoje disponíveis. OBJETIVO: Investigar os efeitos da infusão de NPS sobre a sintomatologia e os potenciais evocados auditivos MMN e P300 em pacientes com esquizofrenia em um ensaio duplo-cego controlado por placebo. MÉTODO: Foram avaliados 12 pacientes com idade entre 25 e 54 anos em tratamento antipsicótico acompanhados no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Cada paciente participou de duas sessões experimentais, uma com infusão de NPS e outra com placebo. Escalas psiquiátricas (BPRS e PANSS) foram aplicadas imediatamente antes da infusão de NPS ou soro glicosado, a cada hora durante a infusão e imediatamente após a realização dos exames de P300 e MMN, realizados após o fim da infusão. RESULTADOS: A infusão de NPS foi associada a um aumento significativo da amplitude do potencial evocado MMN e a uma redução nos escores das escalas de sintomas psiquiátricos BPRS e PANSS em comparação com o placebo. CONCLUSÃO: A infusão de NPS foi associada à melhora dos sintomas de esquizofrenia conforme medidos pela BPRS e PANSS e a um aumento da amplitude do potencial evocado MMN. Não houve efeitos da administração do NPS sobre o potencial evocado P300. / INTRODUCTION: Schizophrenia is a mental disorder characterized by disorganization of several mental processes including cognition. Schizophrenia patients present alterations in the amplitude and latency of auditory evoked potentials P300 and MMN. Most current antipsychotics have little or no effect on the negative symptoms or cognitive impairment in schizophrenia, which led researchers to search for pharmacological alternatives that may counteract these manifestations. Recent evidence suggests that sodium nitroprusside (SNP) is able to ameliorate some of the manifestations associated with schizohrenia that do not respond adequately to currently available treatments. OBJECTIVE: To investigate the effects of SNP on schizophrenia symptoms and on the evoked potentials P300 and MMN in a double-blind, placebocontrolled trial. METHODS: The trial involved 12 patients aged 25-54 years in antipsychotic treatment followed up at the Ribeirã Preto Medical School University Hospital. Each patient attended two experimental sessions, one for the infusion of SNP and another for the infusion of placebo. The Brief Psychiatric Rating Scale (BPRS) and the Positive and Negative Syndromes Scale (PANSS) were completed immediately before the infusion, every consecutive hour, and immediately after the P300 and MMN tests, performed after the end of the infusion. RESULTS: The infusion of SNP was associated with a significant increase in the amplitude of MMN and with a reduction in the psychopathology scores of the BPRS and PANSS compared to placebo. CONCLUSION: The administration of SNP was associated with an improvement in schizophrenia symptoms as measured with the BPRS and PANSS and with an increase in the amplitude of the evoked potential MMN. There were no effects of SNP on the evoled potential P300.

INTRODUÇÃO: A esquizofrenia é um transtorno que se caracteriza pela desorganização de diversos processos mentais, dentre os quais a cognição. Pacientes com esquizofrenia apresentam alterações na amplitude e latência dos potenciais evocados P300 e MMN. A maioria das drogas antipsicóticas atuais têm pouco efeito sobre os sintomas negativos e prejuízos cognitivos dos pacientes, por isso, pesquisadores têm buscado alternativas farmacológicas que possam agir sobre os prejuízos cognitivos e sintomas negativos. Pesquisas recentes demonstraram que o nitroprussiato de sódio (NPS) é capaz de atenuar algumas das manifestações do transtorno que não respondem adequadamente aos tratamentos hoje disponíveis. OBJETIVO: Investigar os efeitos da infusão de NPS sobre a sintomatologia e os potenciais evocados auditivos MMN e P300 em pacientes com esquizofrenia em um ensaio duplo-cego controlado por placebo. MÉTODO: Foram avaliados 12 pacientes com idade entre 25 e 54 anos em tratamento antipsicótico acompanhados no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Cada paciente participou de duas sessões experimentais, uma com infusão de NPS e outra com placebo. Escalas psiquiátricas (BPRS e PANSS) foram aplicadas imediatamente antes da infusão de NPS ou soro glicosado, a cada hora durante a infusão e imediatamente após a realização dos exames de P300 e MMN, realizados após o fim da infusão. RESULTADOS: A infusão de NPS foi associada a um aumento significativo da amplitude do potencial evocado MMN e a uma redução nos escores das escalas de sintomas psiquiátricos BPRS e PANSS em comparação com o placebo. CONCLUSÃO: A infusão de NPS foi associada à melhora dos sintomas de esquizofrenia conforme medidos pela BPRS e PANSS e a um aumento da amplitude do potencial evocado MMN. Não houve efeitos da administração do NPS sobre o potencial evocado P300. / INTRODUCTION: Schizophrenia is a mental disorder characterized by disorganization of several mental processes including cognition. Schizophrenia patients present alterations in the amplitude and latency of auditory evoked potentials P300 and MMN. Most current antipsychotics have little or no effect on the negative symptoms or cognitive impairment in schizophrenia, which led researchers to search for pharmacological alternatives that may counteract these manifestations. Recent evidence suggests that sodium nitroprusside (SNP) is able to ameliorate some of the manifestations associated with schizohrenia that do not respond adequately to currently available treatments. OBJECTIVE: To investigate the effects of SNP on schizophrenia symptoms and on the evoked potentials P300 and MMN in a double-blind, placebocontrolled trial. METHODS: The trial involved 12 patients aged 25-54 years in antipsychotic treatment followed up at the Ribeirã Preto Medical School University Hospital. Each patient attended two experimental sessions, one for the infusion of SNP and another for the infusion of placebo. The Brief Psychiatric Rating Scale (BPRS) and the Positive and Negative Syndromes Scale (PANSS) were completed immediately before the infusion, every consecutive hour, and immediately after the P300 and MMN tests, performed after the end of the infusion. RESULTS: The infusion of SNP was associated with a significant increase in the amplitude of MMN and with a reduction in the psychopathology scores of the BPRS and PANSS compared to placebo. CONCLUSION: The administration of SNP was associated with an improvement in schizophrenia symptoms as measured with the BPRS and PANSS and with an increase in the amplitude of the evoked potential MMN. There were no effects of SNP on the evoled potential P300.

<p>Nitric oxide (NO) is an important chemical factor that controls vascular tone in the cardiovascular system. NO is a vasodilatory molecule that plays a role in blood pressure and blood flow regulation as well as vessel formation and tissue cell proliferation. NO influences the flow by which nutrients and other metabolites required for growth are transported to the tissues. The aim of this study was to investigate if NO, through mediation by the NO donors Sodium Nitroprusside (SNP) and S-Nitrosoglutathione (GSNO) affect growth and oxygen consumption of prenatal broiler chicken. The results indicate that, although the treatments did not have clear significant effects on the embryos or the organs examined, a slight delay in development can be observed in the GSNO treatment embryos. The study could not conclude, however, if this was due to effects of NO donors</p>